Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.